Tag: VLP
Premas Biotech & Oramed announce oral COVID-19 vaccine candidate that produces...
With triple antigen targeting, the vaccine is claimed to offer better protection against COVID-19 variants. While Oravax Medical Inc has been established to accelerate the vaccine’s path to market, clinical trials are expected to commence in Q2 2021......................
Premas Biotech SARS-Cov-2 vaccine candidate moves ahead for animal trials
The four-week placebo-controlled, blinded and randomized tests to be conducted in mice will seek to evaluate safety and examine immune response dose titration in the rodent model................